Strategic Intellectual Property Forum


IP for successful business models

Thursday 27 September 2018

Intellectual property (IP) may adopt many forms - patents, trademarks, goodwill, designs, copyright and know-how. But what all of these forms have in common is that they provide key IP assets potentially with substantial commercial and innovation potential. Knowing how to leverage these IP assets requires a balanced blend of IP awareness, commercial understanding and familiarity with IP portfolio management.

Committed to supporting UK industry, IfM’s Centre for Technology Management (CTM) and Avidity IP launched the Strategic Intellectual Property Forum (SIPF) to help companies understand how to manage and exploit their IP.




Registration and refreshments



Ove Granstrand, Leverhulme Trust visiting professor to the University of Cambridge

Frank Tietze, Centre for Technology Management, IfM & Joeeta Murphy, AvidityIP


IP supporting a flexible business model

Alison McGhee, Head of IP, F-Star


IP Strategies in the medical device industry

Quentin Harmer, CTO and IP manager, Endomag




IP for Energy Industry 4.0

Joan Beckner, Legal & IP Counsel, Department Manager, Schlumberger


Intellectual Property Strategies for Blockchain Software Development

Kevin Fournier, IP Manager, IBM


Panel discussion with speakers



Frank Tietze, Centre for Technology Management, IfM & Joeeta Murphy, AvidityIP





Speakers include


Alison McGhee, Head of IP, F-Star

Alison has over 10 years’ experience of intellectual property in the biotechnology and pharmaceutical industry, including product and platform technology patent portfolio management and managing multi-national litigations and oppositions. Before F-star, she worked at MedImmune (formerly Cambridge Antibody Technology (CAT)) and at the technology transfer office at the University of Cambridge.

She is a European Patent Attorney and a Chartered UK Patent Attorney. She holds an MSc (distinction) in Plant Breeding and Biotechnology from the University of East Anglia (in conjunction with the John Innes Centre) and a BSc (Hons) from the University of St Andrews in Biochemistry with Microbiology and Biotechnology.


Quentin Harmer, CTO and IP manager, Endomag

Dr Quentin Harmer is CTO at Endomag responsible for new product development, IP and global clinical trials.  An engineer and technologist, he has twenty years’ experience in leading the development of advanced medical devices and drug-device combination products.  Quentin works at the interface of technology, medical regulation and clinical practice to develop Endomag’s portfolio of products which help surgeons accurately remove cancers and lymph nodes linked to the cancer. 

Quentin joined Endomagnetics from Vectura Group plc where he led the development of novel inhalers and inhaled therapies for asthma and other lung diseases. Outside of work Quentin can often be found fixing things at a repair café (


Joan Beckner, Legal & IP Counsel, Department Manager, Schlumberger

Joan Froehlich Beckner is a US lawyer and patent attorney with 15 years’ experience in patent litigation and IP counseling, including portfolio development and enforcement strategy, prosecution, opinion work, and contracting.  She has worked as IP | Litigation partner with a large international law firm, including in-court advocacy on behalf of plaintiff-patentees and defendants, and as in-house counsel for a global engineering and manufacturing company and a scientific research company.  Joan’s legal practice has focused on the energy industry, with its wide-ranging mechanical to chemical to software technologies.  She holds BS (Distinction) and MS degrees in petroleum engineering from Stanford University, and a JD (Law Review) from the University of Houston Law Center.

Kevin Fournier, IP Manager, IBM

Kevin provides legal advice and counsel to the IBM business on intellectual property issues in transactions such as technology joint research and development projects, joint ventures, business consulting, applications development and maintenance, strategic outsourcing, mergers and acquisitions, software licensing, patent licensing, and IP assignments.  Kevin also handles invention disclosure review, and patent application review and filing, as well as prosecution of such applications. 


Ove Granstrand, Leverhulme Trust visiting professor to the University of Cambridge

Ove Granstrand was educated at Chalmers University of TechnologyUniversity of Gothenburg, Sweden and Stanford University with graduate degrees in mathematics, economics and engineering and a PhD degree in industrial management and economics. His work experience includes teaching, research and consultancy in various Eastern and Western countries. He serves as Professor in Industrial Management and Economics at Chalmers University of Technology and is founder of CIP – Center for Intellectual Property Studies at Chalmers. His research interest concerns economics and management of technology and innovation. In particular, he has studied innovation, corporate strategy and diversification in multi-technology corporations in Europe, Japan and the USA, as well as various issues related to R&D, intellectual property and intellectual capital more generally.


Frank Tietze, Centre for Technology Management, IfM  

At the Institute for Manufacturing Frank leads the IIPM (Innovation and IP Management) research group at the Centre for Technology Management, University of Cambridge. We take a managerial (firm level) and relational perspective on all things IP (Intellectual Property) within distributed and collaborative (open) innovation processes for emerging (manufacturing) technologies. The group focuses on “how to”-questions thereby enabling practice relevant research, while ensuring academic rigour.  



Joeeta Murphy, AvidityIP    

Joeeta is a Senior Managing Attorney at Avidity IP, a commercially focused firm of Patent Attorneys, and manages the Life Sciences, Pharma and MedTech team in Cambridge and Oxford.  Joeeta has over 23 years experience in the Patent and Trade Mark profession having worked in top tier private practice and as an in-house Attorney in a bio-pharmaceutical company.  Joeeta is widely experienced in drafting, prosecution, EPO oppositions and Appeals in a variety of Life Sciences technologies and has represented clients from SMEs to multinationals and start-ups to Universities. Joeeta’s experience includes handling contracts, licenses, IP Due diligence for M&As, IP Audits, freedom to operate searches and opinions, infringement and validity opinions, competitor reviews and landscaping as well as providing IP training.


Who should attend 

SIPF caters for decision makers in large, mid-caps but also small companies and high-tech start-ups such as CTOs, portfolio managers, VPs Technology, Heads of IP / licensing from the Cambridge cluster and beyond.

Attendance is free of charge, but pre-event registration is required. Come along and engage in an expert community for discussions on strategic IP topics. 

The CTM and Avidity IP are looking forward to welcoming you to the IfM.



The event is kindly supported by: 




For further information please contact:

Events Team

T: +44 (0)1223 748267


Event location